Chemistree Technology Inc. (CSE:CHM) (OTCQB:CHMJF) released some exciting news Monday that will expand its CBD portfolio and give the company exposure to the medical CBD market. Chemistree announced that it has entered into a funding agreement with The Physician’s Choice CBD (PCCBD), a doctor-led medical cannabis company with nine hemp-derived CBD products under its belt.
The Physician’s Choice CBD’s leaders, Dr. Julian Grove and Dr. Peter Kubitz, are both board-certified practicing physicians who specialize in pain management and have over 15 years of experience in private practice. PCCBD has been dedicated to the research, development, and ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.